CITED4 gene therapy: Can it be cited for preventing maladaptive post-ischemic cardiac remodeling?
- PMID: 39317189
- PMCID: PMC11489530
- DOI: 10.1016/j.ymthe.2024.09.012
CITED4 gene therapy: Can it be cited for preventing maladaptive post-ischemic cardiac remodeling?
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
Similar articles
-
Gene delivery of sarcoplasmic reticulum calcium ATPase inhibits ventricular remodeling in ischemic mitral regurgitation.Circ Heart Fail. 2010 Sep;3(5):627-34. doi: 10.1161/CIRCHEARTFAILURE.109.891184. Epub 2010 Jul 15. Circ Heart Fail. 2010. PMID: 20634484 Free PMC article.
-
CITED4 Protects Against Adverse Remodeling in Response to Physiological and Pathological Stress.Circ Res. 2020 Aug 14;127(5):631-646. doi: 10.1161/CIRCRESAHA.119.315881. Epub 2020 May 18. Circ Res. 2020. PMID: 32418505 Free PMC article.
-
miRNAs as therapeutic targets in ischemic heart disease.J Cardiovasc Transl Res. 2010 Jun;3(3):280-9. doi: 10.1007/s12265-010-9173-y. Epub 2010 Mar 30. J Cardiovasc Transl Res. 2010. PMID: 20560049 Review.
-
Adeno-associated virus serotype 9 administered systemically after reperfusion preferentially targets cardiomyocytes in the infarct border zone with pharmacodynamics suitable for the attenuation of left ventricular remodeling.J Gene Med. 2012 Sep-Oct;14(9-10):609-20. doi: 10.1002/jgm.2673. J Gene Med. 2012. PMID: 23065925 Free PMC article.
-
Molecular aspects of ischemic heart disease: ischemia/reperfusion-induced genetic changes and potential applications of gene and RNA interference therapy.J Cardiovasc Pharmacol Ther. 2006 Mar;11(1):17-30. doi: 10.1177/107424840601100102. J Cardiovasc Pharmacol Ther. 2006. PMID: 16703217 Review.
References
-
- Hausenloy D.J., Yellon D.M. Targeting Myocardial Reperfusion Injury — The Search Continues. N. Engl. J. Med. 2015;373:1073–1075. - PubMed
-
- Lerchenmüller C., Hastings M.H., Rabolli C.P., Betge F., Roshan M., Liu L.X., Liu X., Heß C., Roh J.D., Platt C., Bezzerides V. CITED4 gene therapy protects against maladaptive cardiac remodeling after ischemia/reperfusion injury in mice. Mol. Ther. 2024;32:3683–3694. doi: 10.1016/j.ymthe.2024.07.018. - DOI - PubMed
-
- Landmesser U., Wollert K.C., Drexler H. Potential novel pharmacological therapies for myocardial remodelling. Cardiovasc. Res. 2009;81:519–527. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical